Allison Kranyak
Overview
Explore the profile of Allison Kranyak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marquez-Grap G, Kranyak A, Brownstone N, Koo J
J Dermatolog Treat
. 2025 Feb;
36(1):2466635.
PMID: 39988333
One of the most well-known medications for treating delusional infestation (DI) is pimozide. Many patients may be reluctant to initiate treatment unless a medication has anti-pathogenic properties, as they feel...
2.
Haran K, Kranyak A, Johnson C, Smith P, Hunt S, Liao W, et al.
JAAD Case Rep
. 2025 Jan;
55():48-50.
PMID: 39802945
No abstract available.
3.
Haran K, Johnson C, Smith P, Venable Z, Kranyak A, Bhutani T, et al.
Psoriasis (Auckl)
. 2024 Nov;
14:143-152.
PMID: 39564576
Psoriasis is an immune-mediated skin disease known to be associated with a higher risk of cardiometabolic comorbidities such as hypertension, myocardial infarction, and stroke. GLP-1 receptor agonists (GLP-1RAs) are medications...
4.
Haran K, Gondo G, Smith P, Johnson C, Kranyak A, Bhutani T, et al.
J Psoriasis Psoriatic Arthritis
. 2024 Nov;
:24755303241288536.
PMID: 39544334
Psoriasis is an immune-mediated skin disease commonly treated with biologic therapies. While there are currently 12 different biologics approved for psoriasis, there still exists a challenging subset of patients who...
5.
Smith P, Kranyak A, Johnson C, Haran K, Liao W, Bhutani T, et al.
Skin (Milwood)
. 2024 Sep;
8(4):1711-1713.
PMID: 39324151
Chronic pruritis, characterized by persistent itchiness lasting more than six weeks, affects up to 15% of the population, significantly impairing quality of life. Despite its prevalence and impact, there is...
6.
Smith P, Johnson C, Haran K, Orcales F, Kranyak A, Bhutani T, et al.
Curr Dermatol Rep
. 2024 Sep;
13(3):141-147.
PMID: 39301276
Purpose Of Review: Machine learning (ML), a subset of artificial intelligence (AI), has been vital in advancing tasks such as image classification and speech recognition. Its integration into clinical medicine,...
7.
Smith P, Kranyak A, Johnson C, Haran K, Muraguri Snr I, Maurer T, et al.
Psoriasis (Auckl)
. 2024 Sep;
14:93-100.
PMID: 39224150
Introduction: Goeckerman therapy, which combines ultraviolet B (UVB) light with crude coal tar (CCT), remains highly effective for moderate-to-severe psoriasis. While it is rarely still used in the USA as...
8.
The Mediterranean Diet as a Potential Solution to the Gut Microbiome Dysbiosis in Psoriasis Patients
Kranyak A, Haran K, Smith P, Johnson C, Liao W, Bhutani T
J Psoriasis Psoriatic Arthritis
. 2024 Aug;
9(2):69-81.
PMID: 39156223
Background: Adherence to a Mediterranean Diet (MeD) has been associated with lower disease severity in patients with psoriasis. However, the mechanism behind how this diet may lead to disease modification...
9.
Haran K, Kranyak A, Johnson C, Smith P, Farberg A, Bhutani T, et al.
Psoriasis (Auckl)
. 2024 Aug;
14:87-92.
PMID: 39132449
While psoriasis and atopic dermatitis (AD) are two common dermatological conditions, their diagnosis and therapeutic decision-making pathways are often complex. As a result, there has been increased focus on the...
10.
Smith P, Jin J, Spencer R, Elhage K, Johnson C, Haran K, et al.
Dermatol Ther (Heidelb)
. 2024 Jun;
14(8):2277-2283.
PMID: 38940897
Introduction: Psoriasis, a chronic inflammatory skin condition, affects approximately 3.0% of the US population, with patients often experiencing significant sleep disturbances. These disturbances include a higher prevalence of conditions such...